Fortress Biotech, Inc. (FBIO) financial statements (2021 and earlier)

Company profile

Business Address 2 GANSEVOORT STREET
NEW YORK, NY 10014
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments23313783150889870
Cash and cash equivalents23313766114889850
Short-term investments  1836  20
Receivables20146105  
Inventory, net of allowances, customer advances and progress billings11100  
Inventory11100  
Prepaid expense   1   
Disposal group, including discontinued operation  13    
Other undisclosed current assets749221621
Total current assets:26215611118311010070
Noncurrent Assets
Operating lease, right-of-use asset2021
Property, plant and equipment12121210700
Long-term investments and receivables1811 1124
Long-term investments1811 1124
Intangible assets, net (including goodwill)157134361 
Goodwill   1919  
Intangible assets, net (excluding goodwill)157115171 
Restricted cash and investments2171617161515
Other noncurrent assets1101000
Total noncurrent assets:67703063611919
TOTAL ASSETS:32922614124617111989
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:4135343624105
Accounts payable     20
Accrued liabilities292516181094
Employee-related liabilities   1012 1
Taxes payable0      
Interest and dividends payable 110000
Other undisclosed accounts payable and accrued liabilities1191682  
Debt 210132  
Derivative instruments and hedges, liabilities 01000 
Due to related parties 7000  
Deferred revenue and credits11  
Other liabilities5  00  
Other undisclosed current liabilities21101728 (1)
Total current liabilities:4846566757114
Noncurrent Liabilities
Long-term debt and lease obligation751016043232314
Long-term debt, excluding current maturities52776043232314
Operating lease, liability2324
Liabilities, other than long-term debt2755511
Deferred revenue and credits   0
Other liabilities2755511
Other undisclosed noncurrent liabilities7  104 (0)
Total noncurrent liabilities:841086658312415
Total liabilities:132154121125883419
Stockholders' equity
Stockholders' equity attributable to parent10026253385771
Preferred stock0000   
Common stock0000000
Common stock, value, subscriptions 111   
Additional paid in capital583462397364284247212
Accumulated deficit(483)(436)(396)(312)(245)(190)(142)
Stockholders' equity attributable to noncontrolling interest974618684427 
Total stockholders' equity:1977320121838471
TOTAL LIABILITIES AND EQUITY:32922614124617111989

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues463727188161 
Revenue, net188161 
Cost of revenue(79)(18)(6)(4)   
Cost of goods and services sold(15)(11)(6)(4)   
Gross profit:(33)1821184161 
Operating expenses(61)(129)(147)(289)(82)(51)(22)
Other undisclosed operating income  64  1
Operating loss:(94)(111)(120)(101)(66)(51)(21)
Nonoperating income (expense)(9)9(11)3(6)(3)1
Investment income, nonoperating2311001
Interest and debt expense(1)(0)(0)(6)(4)(1)(1)
Other undisclosed income from continuing operations before equity method investments, income taxes1006   
Loss from continuing operations before income taxes:(103)(102)(131)(98)(75)(55)(21)
Income tax expense(0)  (2)   
Loss from continuing operations:(103)(102)(131)(100)(75)(55)(21)
Loss from discontinued operations  (11)    
Loss before gain (loss) on sale of properties:(103)(102)(142)(100)(75)(55)(21)
Other undisclosed net income    41 
Net loss:(103)(102)(142)(100)(71)(54)(21)
Net income attributable to noncontrolling interest56625833165 
Other undisclosed net income attributable to parent      1
Net loss available to common stockholders, diluted:(47)(40)(84)(67)(55)(48)(20)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(103)(102)(142)(100)(71)(54)(21)
Comprehensive loss:(103)(102)(142)(100)(71)(54)(21)
Comprehensive income, net of tax, attributable to noncontrolling interest56625833165 
Comprehensive loss, net of tax, attributable to parent:(47)(40)(84)(67)(55)(48)(21)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: